523 related articles for article (PubMed ID: 21963369)
1. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.
Pittenger C; Bloch MH; Williams K
Pharmacol Ther; 2011 Dec; 132(3):314-32. PubMed ID: 21963369
[TBL] [Abstract][Full Text] [Related]
2. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
Korff S; Harvey BH
Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
[TBL] [Abstract][Full Text] [Related]
3. Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.
Marinova Z; Chuang DM; Fineberg N
Curr Neuropharmacol; 2017; 15(7):977-995. PubMed ID: 28322166
[TBL] [Abstract][Full Text] [Related]
4. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
[TBL] [Abstract][Full Text] [Related]
5. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
Pittenger C; Krystal JH; Coric V
NeuroRx; 2006 Jan; 3(1):69-81. PubMed ID: 16490414
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic dysfunction--newer targets for anti-obsessional drugs.
Bhattacharyya S; Chakraborty K
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):47-55. PubMed ID: 18221217
[TBL] [Abstract][Full Text] [Related]
7. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.
Wu K; Hanna GL; Rosenberg DR; Arnold PD
Pharmacol Biochem Behav; 2012 Feb; 100(4):726-35. PubMed ID: 22024159
[TBL] [Abstract][Full Text] [Related]
8. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder.
Goodman WK; Storch EA; Sheth SA
Am J Psychiatry; 2021 Jan; 178(1):17-29. PubMed ID: 33384007
[TBL] [Abstract][Full Text] [Related]
9. [Neurobiology of obsessive-compulsive disorder].
Endres D; Domschke K; Schiele MA
Nervenarzt; 2022 Jul; 93(7):670-677. PubMed ID: 35725830
[TBL] [Abstract][Full Text] [Related]
10. Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.
Grados M; Sung HM; Kim S; Srivastava S
Drug Dev Res; 2014 Sep; 75(6):372-83. PubMed ID: 25195581
[TBL] [Abstract][Full Text] [Related]
11. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the glutaminergic system for obsessive-compulsive disorder].
Nissen JB; Thomsen PH
Ugeskr Laeger; 2008 Sep; 170(37):2874-6. PubMed ID: 18796282
[TBL] [Abstract][Full Text] [Related]
13. A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
Grados M; Prazak M; Saif A; Halls A
Expert Opin Drug Discov; 2016; 11(1):27-43. PubMed ID: 26558411
[TBL] [Abstract][Full Text] [Related]
14. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
Koo MS; Kim EJ; Roh D; Kim CH
Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383
[TBL] [Abstract][Full Text] [Related]
15. Translational neuroimaging research in pediatric obsessive-compulsive disorder.
MacMaster FP
Dialogues Clin Neurosci; 2010; 12(2):165-74. PubMed ID: 20623921
[TBL] [Abstract][Full Text] [Related]
16. Neurobiology of the obsessive-compulsive spectrum disorders.
Stein DJ
Biol Psychiatry; 2000 Feb; 47(4):296-304. PubMed ID: 10686264
[TBL] [Abstract][Full Text] [Related]
17. Circadian rhythms in obsessive-compulsive disorder.
Lange KW; Lange KM; Hauser J; Tucha L; Tucha O
J Neural Transm (Vienna); 2012 Oct; 119(10):1077-83. PubMed ID: 22543530
[TBL] [Abstract][Full Text] [Related]
18. Reduced anterior cingulate glutamate of comorbid skin-picking disorder in adults with obsessive-compulsive disorder.
Zheng H; Yang W; Zhang B; Hua G; Wang S; Jia F; Guo G; Wang W; Quan D
J Affect Disord; 2020 Mar; 265():193-199. PubMed ID: 32090741
[TBL] [Abstract][Full Text] [Related]
19. The Glutamate and the Immune Systems: New Targets for the Pharmacological Treatment of OCD.
Marazziti D; Albert U; Mucci F; Piccinni A
Curr Med Chem; 2018; 25(41):5731-5738. PubMed ID: 29119912
[TBL] [Abstract][Full Text] [Related]
20. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
O'Neill J; Piacentini J; Chang S; Ly R; Lai TM; Armstrong CC; Bergman L; Rozenman M; Peris T; Vreeland A; Mudgway R; Levitt JG; Salamon N; Posse S; Hellemann GS; Alger JR; McCracken JT; Nurmi EL
Neuropsychopharmacology; 2017 Nov; 42(12):2414-2422. PubMed ID: 28409563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
